Y-family DNA polymerases and their role in tolerance of cellular DNA damage. by Sale, Julian E et al.
Y-family DNA polymerases and their role in tolerance of cellular DNA damage


Julian E Sale1, Alan R Lehmann2 and Roger Woodgate3

1 Division of Protein & Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH, UK; 2Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton BN1 9RQ, UK; 3Laboratory of Genomic Integrity, National Institute of Child Health and Human Development, National Institutes of Health, 9800 Medical Center Drive, Bethesda, MD 20892-3371, USA







	Replication past DNA damage by translesion synthesis (TLS) requires specialised DNA polymerases, most of which belong to the Y-family. They have open structures that can accommodate damaged bases in their active sites and are conserved in all organisms.
	Y-family members have specialised features enabling them to synthesise DNA past specific lesions. As an example, the main UV photoproduct is constrained by pol in a molecular splint such that base pairing is maintained despite the distortion caused by the lesion.
	As these polymerases have a low fidelity on undamaged DNA, they are regulated at several different levels. In E. coli, their concentration is under the control of the SOS response – low in undamaged cells, but induced by damage.
	In vertebrate cells, they are concentrated in replication factories in S phase, especially following DNA damage, but are also specifically regulated at stalled forks within these factories. The sliding clamp accessory protein, PCNA, is a key regulator and all family members have PCNA-binding motifs
	When the replication fork is stalled at damage, PCNA is ubiquitinated. This increases the affinity of the polymerases for PCNA by virtue of the ubiquitin-binding motifs present in all the Y-polymerases.





The past fifteen years have seen an explosion in our understanding of how cells replicate damaged DNA and how this can lead to mutagenesis. The Y-family DNA polymerases lie at the heart of this process, commonly known as translesion DNA synthesis. This family of polymerases has unique features [The style of the journal does not allow the use of ‘phrasings such as ‘here we describe…’ in the Preface. Edits OK? Yes] that enable them to synthesise DNA past damaged bases. However, since they exhibit low-fidelity when copying undamaged DNA, it is essential that they are only called into play when they are absolutely required. Several layers of regulation ensure that this is achieved. 

A finely tuned and complex molecular machine replicates DNA with very high efficiency and astonishing fidelity. However, the price paid for this is that it is easily disturbed by damage on the DNA template. Despite the plethora of mechanisms to repair DNA, it is likely that the replication machinery will encounter lesions in the DNA template during each cell cycle. The catalytic site of the replicative DNA polymerases is compact and intolerant of most DNA lesions. As a consequence DNA synthesis arrests at most forms of DNA damage. This poses a considerable problem for the cell - it must replicate the damaged DNA before mitosis so that a complete copy of the genome is passed to both daughter cells. The solution adopted by cells in every branch of life is known as DNA damage tolerance: DNA is synthesised past the damaged bases, which can be subsequently excised once safely located within duplex DNA, after the replication fork has passed. Direct replication past DNA damage in these circumstances, a process known as translesion DNA synthesis (TLS), is carried out by specialised DNA polymerases, the most abundant class of which are those belonging to the Y-family1. As detailed in Table 1 there are two members of this family in Escherichia coli and Saccharomyces cerevisiae and four members in mammalian cells.

Drawing on examples across all domains of life, this review will examine the principles that govern the ability of the Y-family polymerases to synthesise past damaged DNA and yet allow the cell to restrict the potentially damaging mutagenic activity of these enzymes. After a brief historical introduction, we  focus on the underlying biochemical and structural features of the family and then examine the mechanisms that control their activity. Finally, we summarise the roles of the Y-family polymerases in a number of other processes to illustrate how their properties have been co-opted to meet specialised needs within a cell.

A brief history
Special mechanisms required to replicate past DNA damage were first identified by Rupp and Howard-Flanders in the late 1960s, who showed that, in E. coli, gaps were formed in newly synthesised DNA after UV-irradiation and subsequently sealed2. Although most of these gaps were filled-in by a recombination-mediated “damage avoidance” mechanism, the idea that some of them were filled by an error-prone DNA polymerase was mooted in the early 1970s3. The REV (reversionless) loci in budding yeast4 and umu (UV nonmutable) loci in E. coli ADDIN EN.CITE 5, 6 were postulated to be involved in this error-prone bypass pathway and they were thought (erroneously as it turned out), to somehow lower the fidelity of the replicative polymerases (Supplementary Information S1 (Box)) to allow them to replicate past damaged bases. At about the same time the variant form of the sunlight-sensitive cancer-prone genetic disorder xeroderma pigmentosum (XPV) was shown to be caused by a reduced ability to make intact daughter DNA strands following UV-irradiation7.  

It was more than two decades later that the products of these and related genes were identified. In yeast, the product of the REV1 and REV3 genes were found respectively to be a dCMP transferase8 and DNA polymerase ζ, a B-family polymerase, which was capable of bypassing the major UV photoproduct, the cis-syn cyclobutane thymine dimer, with about 10% efficiency9. Rad30, was subsequently also shown to be a bona fide DNA polymerase, termed pol, that could bypass cis-syn cyclobutane thymine dimers, very efficiently and relatively accurately10.  By the end of 1999, a human homolog of Rad30 had been identified and was shown to be the product of the gene defective in XPV cells  ADDIN EN.CITE 11, 12. At roughly the same time, both the E. coli DinB protein and UmuD'2C complex were also shown to be bona fide TLS polymerases, called E.coli polIV ADDIN EN.CITE 13 and polV ADDIN EN.CITE 14, 15 respectively. Shortly thereafter, a second human ortholog of yeast Rad30 and a human ortholog of E.coli DinB were identified and shown to encode novel TLS polymerase pol ADDIN EN.CITE 16-19 and pol ADDIN EN.CITE 20-23 respectively. Thus, within a period of about 18 months, the field underwent a seismic change from having no clear understanding of the mechanisms of TLS to a defined enzymatic process that is facilitated by specialized DNA polymerases conserved from bacteria to humans. The basic steps of TLS, as shown in Figure 1 and described in more detail below, involve several “polymerase switches”. First, the stalled replicative polymerase must be displaced and replaced with a TLS polymerase, which inserts either correct or incorrect bases opposite the lesion. Extension from the (mis)incorporated base may be performed by the same polymerase, or a second TLS polymerase. Finally, when base-pairing has been restored beyond the lesion, the replicative polymerase regains control ADDIN EN.CITE 18, 24, 25.

The presence of these low-fidelity polymerases in all domains of life, and indeed their expansion in higher organisms, suggests an essential evolutionarily conserved role26. All cells are exposed to DNA insults from both endogenous and exogenous sources, and the Y-family DNA polymerases allow them to tolerate potentially lethal damage.  Sometimes, but not always, however, tolerance is accompanied by unwanted mutagenesis, which can have deleterious consequences. It is crucial therefore to strictly regulate the activity of the Y-family polymerases, so that they are not deployed inappropriately.


Structural and biochemical features 
The key differences between Y-family polymerases (Table 1) and most other polymerases are their ability to replicate past damaged bases and their reduced fidelity on undamaged templates. The features of the polymerases that confer these properties are described in this section.

DNA polymerase fidelity
The structural features of the replicative polymerases are geared towards maximising replication efficiency and fidelity (Supplementary Information S1 (Box)). Surprisingly polymerase fidelity, defined as the ratio of incorporation of the correct over incorrect nucleotide, is determined largely by the efficiency of incorporation of the correct nucleotide rather than efficiency of incorrect nucleotide insertion, which varies relatively little between polymerases27. The general structure of the replicative DNA polymerases has been likened to a right hand, with palm, fingers and thumb domains (Figure 2A).28: The catalytic carboxylate-metal ion complex lies within the palm domain, while the mobile fingers and thumb domains grasp the template and primer to create a tight active site intolerant of misalignment between the template base and incoming nucleotide29, 30 (Fig. 2A). The fingers domain undergoes a significant conformational change during the catalytic cycle as explained in Supplementary Information S1 (Box).

General features of the catalytic domains
Despite poor sequence conservation with the replicative polymerases, the structures of Y-family polymerase catalytic domains reveal a similar overall ‘right hand’ topology. However, their active site is more capacious than that of the replicative polymerases, allowing the accommodation of a bulky adduct on the template base. The finger and thumb domains are stubbier, making fewer DNA contacts with both the DNA and incoming nucleotide, which contributes to the enzymes’ decreased processivity and poorer fidelity. The Y-family polymerases have an additional domain, termed the “Little Finger”, which also mediates DNA contacts close to the lesion site. Indeed, this domain has been implicated in polymerase selectivity for certain lesions ADDIN EN.CITE 31. While these features allow nucleotide incorporation opposite damaged bases, they also militate against accurate and processive replication, and the mutagenicity of the Y-family polymerases is further compounded by a lack of the 3’-5’ proofreading exonuclease activity characteristic of replicative polymerases (Compare Figs 2B and C with Fig 2A). 

Y-family acrobatics
Within these general principles, the Y-family polymerases adopt an impressive array of novel mechanisms to replicate over a diverse range of DNA lesions, an ability that extends even to bypassing short stretches of non-DNA carbon chain 32. Next, we illustrate some of these approaches and features by examining how the structural solutions adopted by Y-family members explain their biochemical properties and ability to replicate particular lesions (Table 1). As mentioned previously and shown in Figure 1, TLS is a multi-step process involving (mis)incorporation opposite the DNA lesion and subsequent extension past the lesion (Fig.1). The polymerases thought to be involved in these different steps in E. coli, S. cerevisiae and human cells are detailed in Figure 3. The eukaryotic B-family enzyme Pol is especially suited to carry out the extension past the DNA lesion.

Dpo4: a model for PolIV/DinB/pol-like polymerases
Solfolobus solfataricus Dpo4 (Fig. 4) was the first Y-family DNA polymerase to be crystallised in a ternary complex with DNA and incoming nucleoside triphosphate33. In the intervening ten years, Dpo4 has been crystallised in the process of facilitating TLS past a broad spectrum of DNA lesions. These structures indicate that Dpo4 is very flexible and can accommodate a plethora of lesions in its active site through a variety of contortions of the primer, template, or incoming nucleoside triphosphate. Interestingly, however, the only lesion that Dpo4 bypasses very efficiently is an abasic site.  Efficient bypass is achieved by displacement of the abasic site into an extra-helical position, with the 5’ undamaged base serving as the template for synthesis34. This results in a -1 frameshift mutation if the primer template does not realign after TLS and provides the structural basis for the high frequency of –1 bp mutations generated by Dpo4 and orthologs, such as E.coli pol IV35 and human pol36.

Dpo4 also uses a similar mechanism of looping out the much larger benzo[a]pyrene diol-epoxide (BPDE) adduct on dexoyguanosine ADDIN EN.CITE 37. The bulky lesion is flipped into a structural gap between the little finger domain and the core domains, so that the correct geometry for TLS occurs.  Archaeal Dpo4 and human pol have strikingly similar structures despite rather poor sequence conservation, with all domains superimposable30. However, subtle differences exist.  In particular, the gap between the little finger domain and the catalytic core is enlarged, which helps explain why these enzymes are able to bypass a BPDE lesion in vitro23 and in vivo38.

Molecular splinting by Polη
Polη is particularly efficient at replicating cyclobutane pyrimidine dimers (CPD). It can do so alone and with high efficiency, incorporating A-A opposite a cis-syn T-T CPD with similar accuracy to unmodified T-T10. This provides a ready explanation for the features of pol-defective XP-V cells and patients. In the absence of pol, other polymerases presumably substitute but with lower accuracy, resulting in higher UV-induced mutagenesis and carcinogenesis. Evidence suggests that either pol or pol together with pol are likely candidates  ADDIN EN.CITE 39, 40. A recent set of structures catching yeast and human polη in the act of bypassing a CPD reveal a number of features that enable this polymerase to be so effective at replicating this common lesion ADDIN EN.CITE 41, 42. The active site of polη is particularly large and is able to accommodate both of the linked thymine bases of the template (Fig. 2C). The CPD is further stabilised such that the linked Ts can pair with the correct incoming dA, thereby allowing the polymerase to extract the correct coding information from the lesion. Since the CPD remains in the duplex after replication, it will continue to introduce distortion, which could contribute to slippage and frameshifts as the newly replicated duplex emerges from the catalytic site. Polη counters this by providing a continuous positively charged molecular surface, created by a specialised β-strand in the little finger domain, which acts to splint the newly synthesised duplex into a stable B-form. Thus, the enzyme is not only able to accurately synthesise across T-T CPDs, it also ensures the reading frame is maintained. Finally, when the CPD emerges from the active site, and the cell is in danger of replicating undamaged DNA with low fidelity, steric clashes ensure that the DNA is displaced from the enzyme, when three bases have been inserted beyond the lesion ADDIN EN.CITE 42.

Pol’s structure confers its unique mutagenic signature
Human pol is unique amongst Y-family polymerases in exhibiting a 105-fold difference in fidelity depending upon the template base. When copying dA, the enzyme efficiently incorporates the correct base dT, with a respectable misincorporation fidelity of 1-2 x10-4. However, when replicating dT, the enzyme misinserts dG 3-10 times more frequently than the correct dA.  How can an enzyme be reasonably accurate when copying dA, but highly error-prone when copying dT? The answer lies in the unique active site of pol and in particular, key residues in the finger domain that restrict positioning of the templating base.  Structural studies reveal that template A is driven into a syn (rather than the normal anti) conformation by Gln 59 and Lys 60 from the finger domain. In such a conformation, there are few hydrogen-bonding opportunities with any incoming nucleotide other than dT in an anti, or so-called “Hoogsteen” conformation43. The same finger domain residues that are important for accurate replication of template dA, are responsible for the high misincorporation seen at template dT44. Side chains protrude into the active site of pol and restrict its size.  As a consequence, the template dT is always held in the anti conformation irrespective of the incoming nucleoside triphosphate. While incoming dA is in the syn conformation and exhibits reduced base stacking, misincorporated dG is in an anti conformation and the mispair is further stabilized by hydrogen bonds on Gln5944.  This restrictive feature of the active site facilitates the correct replication of the important oxidative lesion 8-oxoguanine45. 8-oxoguanine can adopt two alternate conformations (anti or syn) and as a consequence, with most polymerases, it can pair equally well with either dC or dA. However, pol restricts it to the syn conformation, preventing the dual coding properties of the lesion by inhibiting the syn–anti [OK? Yes The journal style does not allow the use of slashes.] conformational equilibrium and promoting formation of the most stable and correct base pair with dC46. These properties may explain the participation of polin a specialized TLS pathway within the mechanism of base excision repair 47.

Base flipping during deoxycytidyl transfer by REV1
The catalytic activity of REV1 is, unusually, restricted to the insertion of dC opposite template dG ADDIN EN.CITE 8, 48 or a limited range of lesions including abasic sites and bulky N2-dG adducts ADDIN EN.CITE 49, 50.  While loss of the catalytic activity of REV1 has no discernable defect on survival of DT40 cells following DNA damage51 or murine development52, it has recently been shown to be required for the ability of budding yeast to survive exposure to 4-nitroquinoline-1-oxide (4-NQO) ADDIN EN.CITE 53. Furthermore the mutation spectrum at abasic sites is altered in mutants lacking the catalytic activity of REV1 generated either during immunoglobulin gene somatic hypermutation in vertebrate cells ADDIN EN.CITE 52, 54, 55 or in yeast cells during abasic site bypass56 . This confirms an in vivo role for the dCMP transferase activity of REV1. The crystal structure ADDIN EN.CITE 57 revealed that, while the enzyme is able to detect the presence of a template dG and select for an incoming dC, it does not do this by detecting correct base pairing. Instead, the template dG is swung out of the helix and temporarily coordinated by a specialised loop within the Little Finger domain. The space previously occupied by the template G, or provided by an abasic site, is instead filled by Arg324 of REV1, which forms hydrogen bonds with the incoming dCTP. This mechanism therefore allows the bypass of bulky dG adducts whilst retaining the specificity for incorporation of the correct dC base. 


Regulation of the Y-family polymerases

While the biochemical activities of the Y-family polymerases promote cell survival by allowing the release of replication blocks, they are also potentially deleterious to the cell. Thus, their access to sites of DNA synthesis must be carefully regulated to avoid unscheduled or extensive mutagenic polymerisation. Managing the balance of appropriate recruitment to undesirable activity is a problem facing all organisms, and despite the apparently different approaches taken to regulate translesion polymerases in prokaryotes and eukaryotes, common themes emerge. In all organisms there appears to exist a spectrum of regulatory mechanisms defined at one end by a simple ‘mass action’ approach, in which the number of active polymerase molecules is regulated, through to exquisitely specific control of protein-protein and protein-DNA interactions. In this section we will explore the strategies for regulating the Y-family polymerases from prokaryotes to mammals.

Regulation of cellular concentrations
The conceptually simplest method for regulating the action of the Y-family polymerases is to adjust their cellular concentrations (Figure 5A). This approach is central to the SOS response in E. coli, during which ~40 genes are up-regulated by DNA damage58. Among these genes are those encoding the two Y-family polymerases, DinB (polIV) and UmuDC (polV) (Figure 4)58. However, transcriptional regulation alone is just one level that E. coli utilizes to keep the polymerases under control. Error-prone polV, made up of heterotrimeric UmuD’2C, is subject to multiple further levels of regulation. First, both UmuD and UmuC proteins are rapidly degraded by the Lon protease59. Any molecules of UmuD that escape proteolysis need to be post-translationally processed by cleavage of the N-terminal 24 amino acids to a mutagenically active form, UmuD' 60. Both UmuD and UmuD' form homodimers, but preferentially heterodimerise and in the heterodimer context, UmuD' is specifically degraded by the ClpXP protease59. Thus, mutagenically active homodimeric UmuD' only accumulates in a cell after severe DNA damage. This delays the appearance of error-prone polV (UmuD’2C) until ~45 mins after the initial DNA damage, thereby allowing the cell time to repair the damage via error-free repair mechanisms, before utilizing the error-prone TLS polymerase to traverse the damage. 

In comparison, transcriptional and translational regulation of Y-family polymerases in eukaryotes is less coordinated and appears not to play a central role as in E. coli. One exception is the profound cell cycle regulation of Rev1 in S. cerevisiae. Rev1 levels increase c. 50-fold during G261. This is achieved substantially at the level of protein stability, REV1 transcript varying by no more than three-fold between G1 and G2 ADDIN EN.CITE 61, 62. However, it is again likely that controlling the number of polymerase molecules provides only a crude degree of regulation and that low levels do not preclude activity. 

Sub-cellular concentrations at [OK? Yes]  replication foci 
A further refinement to the regulation of polymerase levels is to concentrate the enzymes locally in the vicinity of distressed replication forks. This approach appears particularly important to vertebrate cells in which the polymerases accumulate in sub-nuclear foci, visible by either indirect immunofluorescence or by fluorescent protein tagging, following DNA damage (Figure 5B). These foci, which have been termed ‘replication factories’, are thought to contain multiple replication forks, including forks stalled by DNA damage ADDIN EN.CITE 63, 64. Over the past few years sub-nuclear focus formation has been increasingly used as a surrogate for enzyme function. However, the link between the two is far from clear. For instance, mutations in the C-terminal motifs of Polη (see Fig 4 and below) drastically reduce its accumulation in foci, while having rather minimal effects on the ability of the protein to complement the UV sensitivity of an XPV (Polη-deficient) cell line65. This suggests that there may be two stages to the recruitment of the Y-family polymerases. The first promotes an increase in the local concentration of the enzyme in the vicinity of distressed replication forks, while the second, discussed in the following section, results in the selection and loading of the polymerase onto the end of the growing DNA strand to initiate TLS. These two processes are interdependent but distinct and we believe that this distinction is conceptually helpful, as we examine more specific mechanisms that are likely to control polymerase access to a particular primer terminus, be it at a replication fork, or at a post-replicative gap.

Regulation at stalled forks
As already noted, the relatively simple ‘mass action’ approaches to regulating the Y-family polymerases are unlikely to provide sufficiently tight regulation to be safe. Even formation of high local concentrations within replication factories is likely to be unsatisfactory on its own, as each ‘factory’ is a large structure and contains multiple forks (Figure 5B). Consequently it is also necessary to have more specific signals indicating which replication forks require assistance  (Figure 5C). A common feature of impeded replication is the exposure of single-stranded DNA near the stalled fork, and in both prokaryotes and eukaryotes this is likely to be the common denominator for signalling replication distress. While the mechanisms linking single-stranded DNA to polymerase activation are quite distinct in E. coli and in eukaryotes, they achieve the same end, namely the focussing of translesion polymerase activity to where it is needed.

Access to the clamp and PCNA ubiquitination
Fully effective activity by all DNA polymerases requires them to be tethered to the DNA through interaction with the sliding clamp, (-clamp in prokaryotes, PCNA in eukaryotes) (See Figure 1 and 3). Eukaryotes appear to have exploited this interaction as a mechanism for regulating which type of polymerase, replicative or translesion, has access to the primer terminus. Many proteins potentially interact with PCNA via a motif designated as a PIP box66 and pols η, ι and κ all possess PIP box motifs in their non-catalytic C-terminal extensions (Figure 4). The control of which enzymes are bound to PCNA at the primer terminus is partly determined by their widely differing association and dissociation constants, but further specificity is provided by post-translational modification of PCNA itself, principally by ubiquitin and SUMO67. Thus, regulation of these modifications is likely to contribute to controlling the interaction of PCNA with potential client proteins, including the Y-family polymerases. 

Replication arrest leads to the exposure of single stranded DNA, and PCNA mono-ubiquitination provides a key link between this event and the recruitment of the TLS polymerases. PCNA mono-ubiquitination is principally mediated by the E3 ubiquitin ligase Rad18 acting in concert with the E2 enzyme Rad6 ADDIN EN.CITE 68-71, although a number of other proteins have also now been implicated in creation of this modification ADDIN EN.CITE 72, 73. Crucially, the activity of RAD18 in ubiquitinating PCNA is stimulated by its association with single-stranded DNA coated with the single-stranded DNA binding protein, Replication Protein A (RPA)74.

As well as the PIP boxes, all eukaryotic Y-family polymerases have UBM or UBZ ubiquitin-binding motifs (Figure 4), which increase their affinity for ubiquitinated PCNA at the site of blocked replication ADDIN EN.CITE 75-77, and thereby increase the probability of their being employed to replicate the lesion. The use of the term ‘probability’ in this context is important. Recruitment of polymerases into foci, and presumably also to the primer terminus, is highly dynamic. For pol and pol the residence time in sub-nuclear foci is less than one second and what appears to be modulated by ubiquitin binding, for instance, is the residence time of individual molecules in the vicinity of the fork ADDIN EN.CITE 78. 

Although PCNA ubiquitination is central to regulation of translesion synthesis, evidence from chicken DT40 cells and mice carrying a K164R mutation in PCNA has revealed that a component of TLS is independent of PCNA ubiquitination in vertebrates  ADDIN EN.CITE 79-82. As discussed below, at least in DT40, this PCNA ubiquitination-independent TLS appears largely dependent on Rev1  ADDIN EN.CITE 81, 83. 

The role of Rev1
Rev1 plays an additional key non-catalytic role in the control of translesion synthesis, that in vertebrates is at least in part independent of PCNA ubiquitination  ADDIN EN.CITE 81, 83.  The last 100 or so amino acids of vertebrate Rev1 binds pols κ, η and ι ADDIN EN.CITE 84-86, as well as Polζ through its Rev7 subunit87 and disruption of this domain leads to an effectively null phenotype51. Rev1 also interacts with PCNA, suggesting that its role could be as an adaptor between the clamp and the other polymerases, although there is some dispute about which sequences are involved in its interaction with PCNA ADDIN EN.CITE 51, 88-90. The role of the two UBMs of Rev1 is enigmatic. The Rev1 UBMs bind ubiquitin and one of them is needed for cell survival and mutagenesis following DNA damage ADDIN EN.CITE 91, but PCNA ubiquitination is not required for Rev1 function at the replication fork83. This structural role of Rev1 in coordinating TLS polymerases with PCNA appears to be conserved in S. cerevisiae although the way in which it interacts with polη/Rad30 and Rev7 is different ADDIN EN.CITE 90, 92, 93 (Figure 4).

Post-translational modifications 
An additional level of complexity is introduced by the observation that the Y-family polymerases can themselves be post-translationally modified by ubiquitination, phosphorylation and possibly SUMOylation ADDIN EN.CITE 75, 91, 94-97. The best characterised of these modifications is ubiquitination of Polη (Figure 5A). Polη is ubiquitinated in its C-terminus ADDIN EN.CITE 95, by the E3 ubiquitin ligase, Pirh298 and, interestingly, this ubiquitination inhibits its interaction with PCNA ADDIN EN.CITE 95, 98. Polη ubiquitination is reduced following DNA damage, suggesting an additional level of control of Polη recruitment. It remains to be determined whether this mode of regulation applies to other Y-family polymerases but, in addition, there are reports of damage-induced phosphorylation of Rev1 in S. cerevisiae ADDIN EN.CITE 94, 96, and of pol in human cells97. While the biological importance of the former remains to be established, the latter phosphorylation has a clear role in facilitating TLS97. Taken together, these findings suggest that the regulatory mechanisms of these enzymes are rather more complex than initially thought. Indeed, there are reports of a number of other proteins that have been implicated in the recruitment of the Y-family polymerase to the replication fork ADDIN EN.CITE 99-103 and in regulating the ubiquitination of PCNA ADDIN EN.CITE 104-107.

Polymerase selection
Despite this complexity it seems that a basic principle for the recruitment of the Y-family polymerases to sites of arrested replication is control of the affinity of the enzymes for PCNA, or other structures near the fork, through modulation of the number of points of contact. None of these recruitment mechanisms, however, really provides any clear specificity in terms of which polymerase is recruited to a specific lesion. This remains an important question. One obvious selector is the lesion itself. It is self-evident that that once a set of polymerases is recruited to the vicinity of an arrested fork, a polymerase can only be utilised if it can accommodate the damaged template-primer in its active site and carry out a catalytic step before dissociating. Selection will thus be determined by normal enzyme kinetic parameters. The various levels of regulation are summarised schematically in Figure 5.


Timing of lesion bypass

It has been debated for many years whether TLS occurs at the replication fork or whether gaps are left to be sealed post-replicatively behind the fork. Early experiments in both E. coli2 and mammalian cells108 suggested the latter and indeed gave rise to the term post-replication repair to describe the process.  With the discovery of the Y-family polymerases, there was an assumption that they acted at the replication fork, though this has not been shown experimentally. More recent data have provided direct visual evidence for the existence of post-replicative gaps behind the forks in UV-irradiated S. cerevisiae109 and elegant genetic studies, in which either Rad18, Rev3 or Pol were induced only in G2, have indicated that TLS can actually occur in G2 after the bulk of the DNA has been replicated ADDIN EN.CITE 110,111. It is evident therefore, that TLS can occur post-replicatively. Although there are likely to be topological differences between TLS at or behind the fork, this does not necessarily imply major mechanistic differences. TLS at the fork requires that it occurs before the replicative helicase has run sufficiently far ahead to allow downstream re-initiation beyond the lesion, whereas the converse is true for TLS behind the fork. The differences may merely be kinetic, depending on which of these processes occurs first, and this will in turn be dependent on the factors that we have described in the previous sections. On the other hand, genetic studies in UV-irradiated chicken DT40 cells have suggested that Rev1 is involved in promoting TLS at the fork, whereas PCNA ubiquitination is required behind the fork (Figure 5C), suggesting that there are likely to be subtle mechanistic as well as kinetic differences 83, a suggestion supported by a recent study showing altered mutation spectra originating from TLS taking place in S phase as opposed to G2 in mammalian cells 112
 
‘Non canonical’ roles 
In addition to their roles in the replication of damaged DNA, Y-family polymerases have also been co-opted into a number of other related processes (Figure 6). [Bullet points are not within the style of the journals. Could you please modify the section to avoid them? A possibility could be to introduce there that five non-canonical roles have been identified, and then list them as First, second, etc.] 
During development of the immune response, the antibody genes of vertebrates exhibit a particularly high rate of focussed mutagenesis, known as somatic hypermutation, which is driven by Activation Induced Deaminase (AID) 113. Although AID can only deaminate dC to dU, its action gives rise to mutations at all four bases in a series of reactions that critically depend on the Y-family polymerases  ADDIN EN.CITE 114. The dU formed by the action of AID is removed by Uracil DNA Glycosylase (UNG) resulting in an abasic site. Direct replication of this abasic site involves Rev1 and generates mutations at dG/dC basepairs  ADDIN EN.CITE 52, 54, 55. Recognition of dU can also result in the formation of a single strand gap and the filling of these gaps by pol results in mutations at dA/dT basepairs  ADDIN EN.CITE 115, 116 (Figure 6A). 

Other examples of non-canonical roles occur during excision repair processes. Clusters of damaged bases pose a particular problem to cells as excision repair can be affected by adjacent base lesions. Pol has recently been shown to play a role in the repair synthesis of clustered oxidative lesions117 (Figure 6B). Nucleotide excision repair is the central mechanism by which helix-distorting base lesions, including CPDs are removed. It involves the recognition and excision of a single strand tract of DNA containing the damaged base, followed by resynthesis using the undamaged strand as a template. Previously, it had been assumed that this synthesis was carried out by the replicative polymerases, but recently Pol was also shown to be involved particularly during conditions of low deoxyribonucleotide pools 118 (Figure 6C). 





The last fifteen years have seen very significant advances in our understanding of how the Y-family polymerases are able to replicate such a wide range of damaged DNA structures and we have also learned much about the genetics of how these enzymes are controlled. However, there remain a number of future challenges that need to be addressed if we are to have a full understanding of the mechanism and consequences of the replication of damaged DNA, three of which we highlight here.

Despite the impressive array of structures of the catalytic centres of the Y-family polymerases, there remain a number of important structures not yet solved, for example that of multi-subunit E. coli DNA polymerase V. Most notably, we have only incomplete information on the complexes formed by the Y-family polymerases in vivo and practically no structural information on their non-catalytic extensions (Figure 4), with the exception of isolated ubiquitin binding domains ADDIN EN.CITE 77, 125, 126. 

The advent of techniques to visualise structures below the resolution imposed by the diffraction of visible light127 and the development of techniques to monitor the behaviour of single or small ensembles of molecules in living cells may well provide a parallel approach to understanding the molecular choreography of the Y-family polymerases and their accessory factors.

The Y-family polymerases are responsible for the majority of mutagenic events and hence play a central role in carcinogenesis. However, the only member with a proven link to cancer is polη, although polymorphisms in other Y-family polymerases have been linked to the development of certain tumours ADDIN EN.CITE 128. Inhibition of the Y-family polymerases results in a combination of hypersensitivity to killing by DNA damaging agents and, in some cases, reduced damage-induced mutation, suggesting that inhibiting their function may not only sensitise tumours to DNA damaging chemotherapeutics, but also reduce the incidence of chemotherapy-induced secondary tumours, thus making them attractive cancer drug targets. However, it is only very recent work that has really begun to test these ideas in whole animal models. The work of the Walker and Henman labs has shown that inhibition of TLS can not only sensitise a model tumour in vivo to chemotherapy ADDIN EN.CITE 129, but also prevent the acquisition of resistance to chemotherapy130. Further studies of this sort will be essential to determine the promise and limitations of manipulation of translesion synthesis as a potential approach in treating tumours, limiting tumour resistance, and preventing development of secondary malignancies following chemotherapy.
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Figure 1 | The basic mechanism of translesion synthesis. TLS is a multi-step process. Replicative DNA polymerase stalls at a site of DNA damage (red H). TLS polymerases are recruited to the primer terminus  and correct, or incorrect bases are inserted opposite the lesion. The inserted base is subsequently extended to complete TLS131.  All TLS polymerases are distributive and dissociate from the primer terminus after synthesizing a short tract of DNA. They are then quickly replaced by the cell’s replicative polymerase, which completes genome duplication.

Figure 2 | Structures of the Y-family DNA polymerases. A. Structure of the B-family DNA polymerase from the bacteriophage RB69, with DNA and the incoming dCTP opposite dG (PDB: 3NCI)132 shown for comparison to the Y-family structures. The main domains are colour coded Palm - red, Thumb - green, Fingers – blue, Exonuclease – purple, N-terminal domain - yellow. B. Crystal structure of the Sulfolobus solfataricus Y-family polymerase, Dpo4, in a ternary complex with DNA and incoming ddADP (PDB: 1JX4)33. The additional Little Finger domain is shown in purple. Note the absence of an exonuclease domain. C. Crystal structure of the human Y-family DNA polymerase, pol, in a ternary complex with a CPD.  In this view, the 3'T of the CPD is in the active site and is correctly paired with incoming dATP (PDB: 3MR3)  ADDIN EN.CITE 42. The template strand is shown in rust colour, while the primer is olive green.  The incoming dNTP is shown in yellow. The burgundy stick represents the position of the CPD. The small blue spheres represent the metal ions. The protein backbone is represented by ribbon surrounded by semi-transparent solvent accessible surface. This figure was kindly created by Alexandra Vaisman (NICHD/NIH), using the Discovery Studio Visualizer program. 

Figure 3 | Evolutionarily conserved roles of DNA polymerases in TLS.  Replicative polymerases such as E.coli pol III, made up of the core, -clamp and -complex, or eukaryotic pol stall at the site of a DNA lesion (represented in the fig as TT) [shown as a double T? Please describe]. TLS polymerases are recruited to the site via interactions with the replicative sliding processivity clamp (-subunit in E. coli [What are the ‘gamma complex’ and ‘core’, depicted in the schematics? All items shown in the schematics should be explained in the legend] and PCNA in eukaryotes). E. coli has a choice of two Y-family polymerases, pol IV and polV Mut (comprised of UmuD'2C-RecA-ATP133). S. cerevisiae also has a choice of two Y-family polymerases, Rev1 and pol, the product of the Rad30 gene [[What are Rad30, Rev3 and Rev7, shown in the schematics?], as well as the B-family TLS polymerase, pol, a heterodimer of the Rev3 and Rev7 proteins.  In humans, at least five TLS polymerases can be recruited to sites of arrested replication, including pol, pol, pol, Rev1 and pol. The likelihood that this insertion step is error-prone, as shown for E.coli and S.cerevisiae, or error-free, as shown for humans, will depend on the nature of the DNA lesion and the polymerase utilized. The extension step may be facilitated by the same enzyme that performed the (mis)insertion, or by a completely different polymerase.  Once the nascent DNA chain has been extended beyond the lesion, the TLS polymerase is replaced by the cell’s replicative DNA polymerase.

Figure 4 | Domains of the Y-family polymerases. The active sites of the polymerases are contained within the Palm, Thumb, Fingers and Little Finger domains, colour coded as in Fig 2 [OK? Yes]. The additional domains involved in localisation and regulation are: BRCT, breast cancer-associated protein-1 C-terminal domain; NLS, nuclear localization signal; UBM, UBZ, ubiquitin-binding motifs. Species abbreviations: Ec, E. coli; Ss, Sulfolobus solfataricus; Sc, Saccharomyces cerevisiae; Hs, Homo sapiens.

Figure 5 | Different levels of regulation of the Y-family polymerases. 
 (A) Different ways of regulating the cellular concentrations of pol. This can be achieved by regulation of transcription (1), mono-ubiquitination by Pirh2\o "Jung, 2011 #124", which can lead to poly-ubiquitination and degradation by the proteasome (2) or to inactivation following a conformational change\o "Bienko, 2010 #38", \o "Jung, 2011 #124" (3). The ubiquitin (Ub) can be removed by a de-ubiquitinase enzyme (Dub). (B) Accumulation in replication factories. A nucleus in which pol is localized in replication factories is shown (top), with, below, a schematic of polymerases and replication forks that are present in the factories, (C) recruitment of pol by ubiquitinated PCNA at a gap behind the fork (1) or by Rev1 close to the fork (2). RPA, single-stranded DNA binding protein.












E. coli	dinB	pol IV	creates -1 frameshifts when over expressed in vivobypasses N2-dG adducts efficiently and accuratelyinvolved in TLS of alkylation damage in vivo
	umuDC	pol V	major TLS polymerase in E. coli and is able to traverse a vast array of lesionsunique among Y-family polymerases in that it is comprised of a heterotrimer of UmuD’ (~24kDa) and UmuC (~48kDa) to form a ~72 kDa UmuD’2C complexinteracts with RecA and ATP to form the highly active pol V Mut polymerase
S. solfataricus		Dpo4	archaeal ortholog of Ec pol IV and Hs polmultiple crystal structures of Dpo4 in the process of bypassing a variety of DNA lesions have been solved
S. cerevisiae	REV1	Rev1p	specifically incorporates dCMP opposite abasic sites, template G and a limited number of other, minor groove adductsinteracts with B-family TLS polymerase pol (comprised of Rev3/Rev7 proteins) to stimulate pol-dependent TLS in vivo
	RAD30	Pol	first Y-family polymerase to be shown to be a bona fide DNA polymerasecan bypass a TT CPD accurately and efficiently
H. sapiens	REV1	REV1	like the Sc Rev1 protein, it specifically incorporates dCMP opposite dG and abasic sitesacts as scaffold protein that interacts with Y-family polymerases ,  and , as well as B-family TLS polymerase pol (comprised of Rev3/Rev7 proteins)generates mutations at G-C base pairs during immunoglobulin gene somatic hypermutation
	POLH/XPV/RAD30A	Pol	bypasses a T-T CPD efficiently and with the same accuracy as undamaged DNAdefects lead to the sunlight sensitive and cancer-prone xeroderma pigmentosum variant phenotypeaccumulates in replication fociis subject to ubiquitination and phosphorylationgenerates mutations at A-T base pairs during immunoglobulin gene somatic hypermutation	
	POLI/RAD30B	Pol	in human cells protein is 715 amino acids in length, but an additional in-frame 25 amino acids, conserved from frogs to humans, produces a 740 amino acid protein as a minor species (B Coull and ARL, unpublished)has unique replication fidelity, replicating template dA reasonably accurately, but template dT in a highly error-prone manneraccumulates in replication foci, but resides in these foci for a shorter time than pol  ADDIN EN.CITE 78	














Abasic site: Site in DNA, where the base has been lost by hydrolysis of the base-sugar (glycosidic) bond.

Anti/Syn conformation of nucleotides: Nucleotides can exist in two conformations, anti- or syn- depending upon rotation of the base around the glycosidic bond.  In order for normal base pairing to occur in DNA, the nucleotide is usually in the anti-conformation.

Activation Induced Deaminase (AID): An enzyme that hydrolytically deaminates cytosines in nucleic acids resulting in the substitution of cytosines with uracils

B-family polymerase: Based upon phylogenetic relationships, DNA polymerases can be classified into different families. B-family polymerases include E.coli pol II and eukaryotic polymerases , ,  and .

B-form DNA: The most common form of the DNA double helix in aqueous environments, in which the bases are perpendicular to the axis of the helix,

Cyclobutane pyrimidine dimer (CPD): the major UV photoproduct in which two adjacent pyrimidines are joined together by a cyclobutane ring between their 5 and 6 positions. Thymine-Thymine (T-T) dimers are the most abundant CPDs, although C-T, T-C and C-C dimers are also possible. Several isomers of a CPD can exist.  The major isomer is a cis-syn CPD.

Damage tolerance: a general term for mechanisms that allow the replication machinery to complete replication despite the presence of DNA damage, without removing the damage.

dCMP transferase: An enzyme activity that adds dCMP onto the end of a growing DNA chain without the need for a template.

E2 ubiquitin conjugating enzyme: [Glossary definitions should be maximum 3-4 lines. Please shorten.] A class of enzymes responsible, in conjunction with an E3 ubiquitin ligase, for attaching ubiquitin to target proteins. Ubiquitin, after activation, is transferred to an E2 enzyme, , which then interacts with an E3 ubiquitin ligase to effect ubiquitin transfer to the target protein.

E3 ubiquitin ligase: An enzyme that catalyses the transfer of ubiquitin from the E2 enzyme to the target protein.

G-quadruplex: A class of DNA secondary structure formed in regions of G-rich DNA of the general sequence G3-5-L1-7-G3-5-L1-7-G3-5-L1-7-G3-5 (where L can be any base). The structures are characterised by stacks of planar arrays of four Hoogsteen-bonded dG bases coordinated by a monovalent metal ion. [Please note that usually references are not included in the glossary. We do notthink it is necessary.]
 
Non-DNA carbon chain: This simply refers to the replacement of a stretch of DNA with a saturated aliphatic chain. It is, of course, not something that is found in vivo, but the ability of TLS polymerases to bypass such a structure illustrates their broad adaptability when dealing with problematic regions of the genome.

PCNA: Proliferating cell nuclear antigen. The trimeric sliding clamp that tethers DNA polymerases and other factors to DNA, in a sequence independent manner, such that they can readily translocate up and down the duplex DNA. The prokaryotic version, which is almost structurally identical, is a dimeric complex called the -clamp.

Processivity: The ability of a polymerase to extend a growing DNA chain before it dissociates.

Replication factory: The clustering of replication and repair proteins into discrete subnuclear foci, visible under the light microscope, suggests that multiple replication forks can group together in what has been termed a replication factory. 

Replication fork: The point on a replicating DNA molecule where replication is actually taking place and one parental strand generates two daughter strands in a Y-like structure.

Replication Protein A (RPA): Eukaryotic protein that binds specifically to single-stranded DNA.

SOS response: Following DNA damage to E. coli, and a few related species of bacteria, 40-50 genes are induced, including several DNA repair proteins. This is known as the SOS response.

SUMO: Small ubiquitin-like modifier. A post-translation modification related to ubiquitin. Like ubiquitination, SUMOylation can alter interactions with other proteins

Ubiquitin: A 76 amino acid peptide that can be conjugated to proteins either singly (monoubiquitination) or in a variety of chains (polyubiquitination). It tags proteins for degradation but is now known to also control cell physiology principally through modulating protein-protein interactions. [Edits to shorten OK? Yes]
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